Sign up to save your podcasts
Or
Share The SWORD Study: A New Two-Drug Combo for HIV
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The SWORD Study: A New Two-Drug Combo for HIV
Dr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.
View all episodes
By MedscapeDr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.